SAIC secures position on US DoD's $900m contract for CBRN support
Science Applications International (SAIC) has a secured a position in a $900m multiple-award contract providing support to the US Department of Defence's (DoD) Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD).
Under the indefinite delivery / indefinite quantity (IDIQ) contract, the company will provide chemical, biological, radiological and nuclear (CBRN) support to US military services.
The three-year contract covers provision of services, including performance-based logistics, operation maintenance and supply chain support, and features an additional one-year option.
SAIC US Army Customer Group senior vice-president and general manager Jim Scanlon said: "We are proud to continue our support to the JPEO-CBD by bringing our logistics, supply chain, and CBRNE knowledge and experience to provide best-in-class solutions to their joint project managers.
"SAIC will partner with the JPEO-CBD to provide affordable logistics support to sustain and meet global force readiness requirements."
The contract has been awarded under the Joint Enterprise-Contracted Logistics and Services Support (JE-CLaSS) vehicle.
Along with SAIC, the US DoD awarded the contract to nine other companies, including Aktarius, Allied Technical Services, AQuate II, Axseum Solutions, KD Analytical Consulting, Murtech, Omega Consultants, Camber Corporation and Battelle, reported DefenseWorld.
The US Army maintains an inventory of chemical and biological detection, personal protection, and equipment in the US and ten other countries worldwide.
It recently announced new measures to manage toxins used by the Biological Select Agents and Toxins Task Force.
The move follows an investigation into the accidental shipment of live anthrax spores from Dugway Proving Ground, Utah, to labs in nine countries and the US last year.
Image: A team of nuclear, biological, and chemical (NBC) disposal technicians. Photo: courtesy of US Navy photo by Photographer's Mate 2nd Class Jeffrey Lehrberg.